JNJ-17216498

· Alza Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ-17216498, covering 2014-05-23 to 2014-05-23. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Effectiveness Study of a Single Dose of JNJ-17216498 in Patients With Narcolepsy [Phase 2]